Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of ABCA7 in Alzheimer’s disease: evidence from genomics, transcriptomics and methylomics
Arne De Roeck, Christine Van Broeckhoven, Kristel Sleegers
Acta Neuropathologica (2019) Vol. 138, Iss. 2, pp. 201-220
Open Access | Times Cited: 175

Showing 26-50 of 175 citing articles:

The ABC's of Alzheimer risk gene ABCA7
Lena Duchateau, Nicole Wawrzyniak, Kristel Sleegers
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3629-3648
Open Access | Times Cited: 9
Demyelination-derived lysophosphatidylserine promotes microglial dysfunction and neuropathology in a mouse model of Alzheimer’s disease
Yubo Zhou, Zonghui Huang, Bolong Lin, et al.
Cellular and Molecular Immunology (2025)
Closed Access | Times Cited: 1
The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer’s Disease
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 4, pp. 1564-1582
Closed Access | Times Cited: 59
ABCA7 and the altered lipidostasis hypothesis of Alzheimer's disease
Nicholas N. Lyssenko, Domenico Praticò
Alzheimer s & Dementia (2020) Vol. 17, Iss. 2, pp. 164-174
Open Access | Times Cited: 55
Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease
Richard D. Semba
Advances in Nutrition (2020) Vol. 11, Iss. 4, pp. 760-772
Open Access | Times Cited: 53
Nucleocytoplasmic Transport: Regulatory Mechanisms and the Implications in Neurodegeneration
Baojin Ding, Masood Sepehrimanesh
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4165-4165
Open Access | Times Cited: 53
Challenge accepted: uncovering the role of rare genetic variants in Alzheimer’s disease
Marzieh Khani, Elizabeth Gibbons, José Brás, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 34
Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration
Jannis Kountouras, Michael Doulberis, Apostolis Papaefthymiou, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 504-504
Open Access | Times Cited: 18
Discovery of an evodiamine derivative for PI3K/AKT/GSK3β pathway activation and AD pathology improvement in mouse models
Shuo Pang, Siyuan Li, Hanzeng Cheng, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 15
Open Access | Times Cited: 17
The Abca7V1613M variant reduces Aβ generation, plaque load, and neuronal damage
Claire A. Butler, Adrian Mendoza Arvilla, Giedre Milinkeviciute, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 7, pp. 4914-4934
Open Access | Times Cited: 7
Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease
Shivani Chib, Bhaskar Jyoti Dutta, Rishabh Chalotra, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 7
Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models
Giovanna Cenini, Matthias Hebisch, Vira Iefremova, et al.
Molecular and Cellular Neuroscience (2020) Vol. 110, pp. 103568-103568
Closed Access | Times Cited: 42
Alzheimer’s Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α
Francisco Sáez-Orellana, Jean‐Noël Octave, Nathalie Pierrot
Cells (2020) Vol. 9, Iss. 5, pp. 1215-1215
Open Access | Times Cited: 41
Omics-based biomarkers discovery for Alzheimer's disease
Qiaolifan Aerqin, Zuo-Teng Wang, Kaimin Wu, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 12
Closed Access | Times Cited: 27
Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders
Marta Turri, Cinzia Marchi, Maria Pia Adorni, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1867, Iss. 5, pp. 159123-159123
Closed Access | Times Cited: 26
Intersectionality in Alzheimer's Disease: The Role of Female Sex and Black American Race in the Development and Prevalence of Alzheimer's Disease
Maria Misiura, Brittany Butts, Bruno L. Hammerschlag, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 1019-1036
Open Access | Times Cited: 16
Gene Expression Profiling as a Novel Diagnostic Tool for Neurodegenerative Disorders
Olaia Martínez-Iglesias, Vinogran Naidoo, Juan C. Carril, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5746-5746
Open Access | Times Cited: 14
Insights into the Neuroprotective Potential of Epicatechin: Effects against Aβ-Induced Toxicity in Caenorhabditis elegans
Begoña Ayuda‐Durán, Lidia Garzón-García, Susana González‐Manzano, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 79-79
Open Access | Times Cited: 6
Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System
Maria Pia Villa, Jingyun Wu, Stefanie Hansen, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 740-740
Open Access | Times Cited: 6
New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease
Yuan Cao, Linwei Zhao, Zixin Chen, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 6
coMethDMR: accurate identification of co-methylated and differentially methylated regions in epigenome-wide association studies with continuous phenotypes
Lissette Gomez, Gabriel Odom, Juan I. Young, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 17, pp. e98-e98
Open Access | Times Cited: 37
Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level
Sweilem B. Al Rihani, Lucy I. Darakjian, Malavika Deodhar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3742-3742
Open Access | Times Cited: 32
Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseases
Federica Perrone, Rita Cacace, Julie van der Zee, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90
Laura Heath, John C. Earls, Andrew T. Magis, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Lipid mediated brain disorders: A perspective
Anju Singh, Samiksha Kukal, Neha Kanojia, et al.
Prostaglandins & Other Lipid Mediators (2023) Vol. 167, pp. 106737-106737
Closed Access | Times Cited: 13

Scroll to top